York Charles N.'s most recent trade in Day One Biopharmaceuticals Inc was a trade of 7,875 Common Stock done . Disclosure was reported to the exchange on Feb. 15, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Day One Biopharma Inc | Charles N. York | COO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2026 | 7,875 | 318,090 | - | - | Common Stock | |
| Day One Biopharma Inc | Charles N. York | COO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2026 | 7,875 | 118,125 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | Charles N. York | COO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2026 | 6,625 | 72,875 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | Charles N. York | COO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2026 | 6,625 | 46,375 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | Charles N. York | COO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2026 | 6,625 | 310,215 | - | - | Common Stock | |
| Day One Biopharma Inc | Charles N. York | COO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2026 | 6,625 | 303,590 | - | - | Common Stock | |
| Day One Biopharma Inc | Charles N. York | COO and CFO | Sale of securities on an exchange or to another person at price $ 11.60 per share. | 15 Feb 2026 | 6,065 | 312,025 | - | 11.6 | 70,359 | Common Stock |
| Day One Biopharma Inc | Charles N. York | COO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2026 | 2,250 | 6,750 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | Charles N. York | COO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2026 | 2,250 | 296,965 | - | - | Common Stock | |
| Day One Biopharma Inc | Charles N. York | COO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2026 | 188,000 | 188,000 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharma Inc | Charles N. York | COO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2026 | 126,000 | 126,000 | - | - | Restricted Stock Units | |
| Day One Biopharma Inc | Charles N. York | COO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2025 | 6,625 | 53,000 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | Charles N. York | COO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2025 | 6,625 | 298,777 | - | - | Common Stock | |
| Day One Biopharma Inc | Charles N. York | COO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2025 | 6,625 | 292,152 | - | - | Common Stock | |
| Day One Biopharma Inc | Charles N. York | COO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2025 | 6,625 | 79,500 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | Charles N. York | COO and CFO | Sale of securities on an exchange or to another person at price $ 8.91 per share. | 15 Nov 2025 | 4,062 | 294,715 | - | 8.9 | 36,212 | Common Stock |
| Day One Biopharma Inc | Charles N. York | COO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2025 | 2,250 | 9,000 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | Charles N. York | COO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2025 | 2,250 | 285,527 | - | - | Common Stock | |
| Day One Biopharma Inc | Charles N. York | COO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2025 | 1,375 | 0 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | Charles N. York | COO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2025 | 1,375 | 283,277 | - | - | Common Stock | |
| Day One Biopharma Inc | Charles N. York | COO and CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 06 Nov 2025 | 497,667 | 0 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharma Inc | Charles N. York | COO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2025 | 497,667 | 497,667 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharma Inc | Charles N. York | COO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2025 | 162,000 | 162,000 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharma Inc | Charles N. York | COO and CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 06 Nov 2025 | 162,000 | 0 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharma Inc | Charles N. York | COO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2025 | 162,000 | 162,000 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharma Inc | Charles N. York | COO and CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 06 Nov 2025 | 162,000 | 0 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharma Inc | Charles N. York | COO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2025 | 151,000 | 151,000 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharma Inc | Charles N. York | COO and CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 06 Nov 2025 | 151,000 | 0 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharma Inc | Charles N. York | COO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2025 | 116,000 | 116,000 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharma Inc | Charles N. York | COO and CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 06 Nov 2025 | 116,000 | 0 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharma Inc | Charles N. York | COO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2025 | 6,625 | 86,125 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | Charles N. York | COO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2025 | 6,625 | 282,106 | - | - | Common Stock | |
| Day One Biopharma Inc | Charles N. York | COO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2025 | 6,625 | 275,481 | - | - | Common Stock | |
| Day One Biopharma Inc | Charles N. York | COO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2025 | 6,625 | 59,625 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | Charles N. York | COO and CFO | Sale of securities on an exchange or to another person at price $ 6.77 per share. | 15 Aug 2025 | 4,106 | 278,000 | - | 6.8 | 27,786 | Common Stock |
| Day One Biopharma Inc | Charles N. York | COO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2025 | 2,250 | 11,250 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | Charles N. York | COO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2025 | 2,250 | 268,856 | - | - | Common Stock | |
| Day One Biopharma Inc | Charles N. York | COO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2025 | 1,375 | 266,606 | - | - | Common Stock | |
| Day One Biopharma Inc | Charles N. York | COO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2025 | 1,375 | 1,375 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2025 | 6,625 | 66,250 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2025 | 6,625 | 269,513 | - | - | Common Stock | |
| Day One Biopharma Inc | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2025 | 6,625 | 262,888 | - | - | Common Stock | |
| Day One Biopharma Inc | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2025 | 6,625 | 92,750 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | Charles N. York | COO, CFO AND SECRETARY | Sale of securities on an exchange or to another person at price $ 6.26 per share. | 15 May 2025 | 4,282 | 265,231 | - | 6.3 | 26,796 | Common Stock |
| Day One Biopharma Inc | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2025 | 2,250 | 13,500 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2025 | 2,250 | 256,263 | - | - | Common Stock | |
| Day One Biopharma Inc | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2025 | 1,375 | 2,750 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2025 | 1,375 | 254,013 | - | - | Common Stock | |
| Day One Biopharma Inc | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 6,625 | 257,008 | - | - | Common Stock | |
| Day One Biopharma Inc | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 6,625 | 250,383 | - | - | Common Stock | |
| Day One Biopharma Inc | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 6,625 | 99,375 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 6,625 | 72,875 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | Charles N. York | COO, CFO AND SECRETARY | Sale of securities on an exchange or to another person at price $ 11.96 per share. | 15 Feb 2025 | 4,370 | 252,638 | - | 12.0 | 52,278 | Common Stock |
| Day One Biopharma Inc | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 2,250 | 243,758 | - | - | Common Stock | |
| Day One Biopharma Inc | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 2,250 | 15,750 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 1,375 | 4,125 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 1,375 | 241,508 | - | - | Common Stock | |
| Day One Biopharma Inc | Charles N. York | COO, CFO AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 162,000 | 162,000 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharma Inc | Charles N. York | COO, CFO AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 106,000 | 106,000 | - | - | Restricted Stock Units | |
| Day One Biopharma Inc | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 6,625 | 242,735 | - | - | Common Stock | |
| Day One Biopharma Inc | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 6,625 | 79,500 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | Charles N. York | COO, CFO AND SECRETARY | Sale of securities on an exchange or to another person at price $ 13.21 per share. | 15 Nov 2024 | 2,602 | 240,133 | - | 13.2 | 34,373 | Common Stock |
| Day One Biopharma Inc | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 2,250 | 18,000 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 2,250 | 236,110 | - | - | Common Stock | |
| Day One Biopharma Inc | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 1,375 | 5,500 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 1,375 | 233,860 | - | - | Common Stock | |
| Day One Biopharma Inc | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 6,625 | 86,125 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 6,625 | 235,118 | - | - | Common Stock | |
| Day One Biopharma Inc | Charles N. York | COO, CFO AND SECRETARY | Sale of securities on an exchange or to another person at price $ 14.00 per share. | 15 Aug 2024 | 2,633 | 232,485 | - | 14.0 | 36,860 | Common Stock |
| Day One Biopharma Inc | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 2,250 | 228,493 | - | - | Common Stock | |
| Day One Biopharma Inc | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 2,250 | 20,250 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 1,375 | 226,243 | - | - | Common Stock | |
| Day One Biopharma Inc | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 1,375 | 6,875 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 6,625 | 227,543 | - | - | Common Stock | |
| Day One Biopharma Inc | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 6,625 | 92,750 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | Charles N. York | COO, CFO AND SECRETARY | Sale of securities on an exchange or to another person at price $ 16.08 per share. | 15 May 2024 | 2,675 | 224,868 | - | 16.1 | 43,011 | Common Stock |
| Day One Biopharma Inc | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 2,250 | 220,918 | - | - | Common Stock | |
| Day One Biopharma Inc | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 2,250 | 22,500 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 1,375 | 8,250 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 1,375 | 218,668 | - | - | Common Stock | |
| Day One Biopharma Inc | Charles N. York | COO, CFO AND SECRETARY | Sale of securities on an exchange or to another person at price $ 17.89 per share. | 01 May 2024 | 52,183 | 225,571 | - | 17.9 | 933,397 | Common Stock |
| Day One Biopharma Inc | Charles N. York | COO, CFO AND SECRETARY | Sale of securities on an exchange or to another person at price $ 17.85 per share. | 01 May 2024 | 8,078 | 217,293 | - | 17.9 | 144,214 | Common Stock |
| Day One Biopharma Inc | Charles N. York | COO, CFO AND SECRETARY | Sale of securities on an exchange or to another person at price $ 17.90 per share. | 01 May 2024 | 200 | 225,371 | - | 17.9 | 3,579 | Common Stock |
| Day One Biopharma Inc | Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 6,625 | 280,420 | - | - | Common Stock | |
| Day One Biopharma Inc | N. York Charles | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 6,625 | 99,375 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | N. York Charles | COO, CFO AND SECRETARY | Sale of securities on an exchange or to another person at price $ 15.25 per share. | 15 Feb 2024 | 2,666 | 277,754 | - | 15.2 | 40,651 | Common Stock |
| Day One Biopharma Inc | York N. Charles | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 2,250 | 273,795 | - | - | Common Stock | |
| Day One Biopharma Inc | York Charles N. | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 2,250 | 24,750 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | York Charles N. | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 1,375 | 9,625 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | Charles York N. | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 1,375 | 271,545 | - | - | Common Stock | |
| Day One Biopharma Inc | N. Charles York | COO, CFO and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 162,000 | 162,000 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharma Inc | York Charles N. | COO, CFO and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 106,000 | 106,000 | - | - | Restricted Stock Units | |
| Day One Biopharma Inc | Charles N. York | COO, CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2023 | 2,250 | 268,423 | - | - | Common Stock | |
| Day One Biopharma Inc | Charles N. York | COO, CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2023 | 2,250 | 29,250 | - | - | Restricted Stock Units | |
| Day One Biopharma Inc | Charles N. York | COO, CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2023 | 1,375 | 266,173 | - | - | Common Stock | |
| Day One Biopharma Inc | Charles N. York | COO, CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2023 | 1,375 | 12,375 | - | - | Restricted Stock Units | |
| Day One Biopharma Inc | Charles N. York | COO, CFO and Secretary | Sale of securities on an exchange or to another person at price $ 13.86 per share. | 15 Aug 2023 | 922 | 267,501 | - | 13.9 | 12,779 | Common Stock |
| Day One Biopharma Inc | Charles N. York | COO, CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 2,250 | 31,500 | - | - | Restricted Stock Units | |
| Day One Biopharma Inc | Charles N. York | COO, CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 2,250 | 265,753 | - | - | Common Stock | |
| Day One Biopharma Inc | Charles N. York | COO, CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 1,375 | 263,503 | - | - | Common Stock | |
| Day One Biopharma Inc | Charles N. York | COO, CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 1,375 | 13,750 | - | - | Restricted Stock Units |